Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2023 Mar 24;13:1096341. doi: 10.3389/fonc.2023.1096341

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright © 2023 Xia, Li, Sun, Liu, Xu, An, Xu, Zhang, Zhong, Zeng, Ma, He, Zhang, Guan, Li and Wang

This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

PMC Copyright notice

The co-expression between TIGIT and other common immune checkpoints and the drug response of sunitinib between high or low TIGIT expression patients. (A) TIGIT was significantly positive co-expression with PDCD1. (B) TIGIT was significantly positive co-expression with CD247. (C) TIGIT was significantly positive co-expression with CTLA4. (D) High expression of TIGIT was associated with a significantly higher drug sensitivity of sunitinib in KIRC. (E) TIGIT was significantly positively correlated with the drug sensitivity of sunitinib in KIRC.